From: A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients
Erythrocyte mediated steroid therapy | Ordinary therapy | P value | |
---|---|---|---|
Mean Shwachman index at enrolment (95% CI) | 71.3 (36.2–106.4) | 70.9 (41.3–100.5) | 0.73 |
Mean Shwachman index at 12 months of follow up (95% CI) | 62.6 (20.0–103.2) | 68.4 (39.2–97.6) | 0.68 |
Mean Shwachman index at 24 months of follow up (95% CI) | 66.8 (21.9–111.7) | 68.0 (37.6–98.4) | 0.83 |
Mean Crispin index at enrollment (95% CI) | 13.7 (4.5–22.6) | 12.7 (5.3–20.1) | 0.76 |
Mean Crispin index at 24 months of follow up (95% CI) | 13.6 (5.2–22.0) | 12.9 (5.9–19.9) | 0.48 |